全文获取类型
| 收费全文 | 84060篇 |
| 免费 | 6850篇 |
| 国内免费 | 1499篇 |
专业分类
| 耳鼻咽喉 | 629篇 |
| 儿科学 | 709篇 |
| 妇产科学 | 517篇 |
| 基础医学 | 3897篇 |
| 口腔科学 | 2321篇 |
| 临床医学 | 12567篇 |
| 内科学 | 7230篇 |
| 皮肤病学 | 401篇 |
| 神经病学 | 2220篇 |
| 特种医学 | 13671篇 |
| 外国民族医学 | 19篇 |
| 外科学 | 5633篇 |
| 综合类 | 16444篇 |
| 现状与发展 | 7篇 |
| 一般理论 | 39篇 |
| 预防医学 | 16919篇 |
| 眼科学 | 457篇 |
| 药学 | 3839篇 |
| 281篇 | |
| 中国医学 | 2215篇 |
| 肿瘤学 | 2394篇 |
出版年
| 2024年 | 58篇 |
| 2023年 | 1335篇 |
| 2022年 | 1998篇 |
| 2021年 | 3368篇 |
| 2020年 | 3571篇 |
| 2019年 | 2646篇 |
| 2018年 | 2583篇 |
| 2017年 | 2524篇 |
| 2016年 | 2708篇 |
| 2015年 | 2591篇 |
| 2014年 | 5928篇 |
| 2013年 | 5919篇 |
| 2012年 | 5733篇 |
| 2011年 | 6140篇 |
| 2010年 | 5334篇 |
| 2009年 | 4884篇 |
| 2008年 | 5045篇 |
| 2007年 | 4947篇 |
| 2006年 | 4381篇 |
| 2005年 | 3613篇 |
| 2004年 | 2920篇 |
| 2003年 | 2368篇 |
| 2002年 | 1884篇 |
| 2001年 | 1600篇 |
| 2000年 | 1241篇 |
| 1999年 | 960篇 |
| 1998年 | 767篇 |
| 1997年 | 685篇 |
| 1996年 | 550篇 |
| 1995年 | 545篇 |
| 1994年 | 425篇 |
| 1993年 | 286篇 |
| 1992年 | 223篇 |
| 1991年 | 281篇 |
| 1990年 | 257篇 |
| 1989年 | 234篇 |
| 1988年 | 233篇 |
| 1987年 | 195篇 |
| 1986年 | 186篇 |
| 1985年 | 185篇 |
| 1984年 | 208篇 |
| 1983年 | 139篇 |
| 1982年 | 161篇 |
| 1981年 | 111篇 |
| 1980年 | 123篇 |
| 1979年 | 54篇 |
| 1978年 | 68篇 |
| 1977年 | 72篇 |
| 1976年 | 62篇 |
| 1975年 | 46篇 |
排序方式： 共有10000条查询结果，搜索用时 31 毫秒
81.
82.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献83.
Adam Wagstaff 《Health economics》2019,28(6):765-781
In the “basic” approach, medical expenses are catastrophic if they exceed a prespecified percentage of consumption or income; the approach tells us if expenses cause a large percentage reduction in living standards. The ability‐to‐pay (ATP) approach defines expenses as catastrophic if they exceed a prespecified percentage of consumption less expenses on nonmedical necessities or an allowance for them. The paper argues that the ATP approach does not tell us whether expenses are large enough to undermine a household's ability to purchase nonmedical necessities. The paper compares the income‐based and consumption‐based variants of the basic approach, and shows that if the individual is a borrower after a health shock, the income‐based ratio will exceed the consumption‐based ratio, and both will exceed the more theoretically correct Flores et al. ratio; whereas if the individual continues to be a saver after a health shock, the ordering is reversed and the income‐based ratio may not overestimate Flores et al.'s ratio. Last, the paper proposes a lifetime money metric utility (LMMU) approach defining medical expenses as catastrophic in terms of their lifetime consequences. Under certain assumptions, the LMMU and Flores et al. approaches are identical, and neither requires data on how households finance their medical expenses. 相似文献
84.
85.
86.
87.
Maximilian Kreibich Tobias Soekeland Friedhelm Beyersdorf Joseph E. Bavaria Holger Schröfel Martin Czerny Bartosz Rylski 《The Journal of thoracic and cardiovascular surgery》2019,157(1):26-34.e1
Objective
The study objective was to screen patients with acute type A aortic dissection for anatomic feasibility of ascending aortic endovascular treatment with a valve-carrying conduit.Methods
High-quality computed tomography scans of 167 patients were available for screening. Aortic dimensions were measured using multiplanar reconstruction in the plane perpendicular to the manually corrected aortic center line. The simulated stent-graft 10-mm–long landing zones were measured starting at the sinotubular junction (proximal landing zone) and ending at the brachiocephalic trunk (distal landing zone). Exclusion criterion was an entry within the aortic root or the landing zone.Results
In 113 patients (68%), the entry was in a coverable zone in the ascending aorta with sufficient proximal and distal landing zone or in more distal aortic segments. In these patients, the median distance between the proximal and distal landing zone was 89.1 (first quartile: 80.0 mm; third quartile: 101.2 mm) and the median diameter difference was 5.0 mm (2.0; 10.1) (12.3 [4.9; 23.0] %). The diameter difference was less than 2 mm in 32 patients (28%), between 6 mm and 10 mm in 20 patients (18%), between 10 mm and 14 mm in 11 patients (10%), and 14 mm or greater in 10 patients (9%).Conclusions
Two thirds of all patients who present with type A dissections are potential candidates for treatment with endovascular valve–carrying conduits, but most patients would require tapered stent-grafts. 相似文献88.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献89.
90.